Browse by UCL Departments and Centres
![[up]](/style/images/multi_up.png)
Up a levelGroup by: Author | Type
Number of items: 107.
A
Abdul-Aziz, AM;
Shafat, MS;
Sun, Y;
Marlein, CR;
Piddock, RE;
Robinson, SD;
Edwards, DR;
... Rushworth, SA; + view all
(2018)
HIF1α drives chemokine factor pro-tumoral signaling pathways in acute myeloid leukemia.
Oncogene
, 37
(20)
pp. 2676-2686.
10.1038/s41388-018-0151-1.
|
 |
|
Aguiar, P;
Azevedo, O;
Pinto, R;
Marino, J;
Cardoso, C;
Sousa, N;
Cunha, D;
... Ducla Soares, JL; + view all
(2018)
Biomarkers of Myocardial Fibrosis: Revealing the Natural History of Fibrogenesis in Fabry Disease Cardiomyopathy.
Journal of the American Heart Association
, 7
(6)
10.1161/JAHA.117.007124.
|
|
|
Arends, M;
Biegstraaten, M;
Wanner, C;
Sirrs, S;
Mehta, A;
Elliott, PM;
Oder, D;
... Hollak, CEM; + view all
(2018)
Agalsidase alfa versus agalsidase beta for the treatment of Fabry disease: an international cohort study.
Journal of Medical Genetics
, 55
(5)
pp. 351-358.
10.1136/jmedgenet-2017-104863.
|
|
|
Auner, HW;
Yong, KL;
(2018)
More convenient proteasome inhibition for improved outcomes.
Lancet Oncology
, 19
(7)
pp. 856-858.
10.1016/S1470-2045(18)30411-X.
|
|
B
|
Backen, AC;
Lopes, A;
Wasan, H;
Palmer, DH;
Duggan, M;
Cunningham, D;
Anthoney, A;
... Valle, JW; + view all
(2018)
Circulating biomarkers during treatment in patients with advanced biliary tract cancer receiving cediranib in the UK ABC-03 trial.
British Journal of Cancer
, 119
pp. 27-35.
10.1038/s41416-018-0132-8.
|
|
|
Bazarbachi, A;
Boumendil, A;
Finel, H;
Mohty, M;
Castagna, L;
Peggs, KS;
Blaise, D;
... Sureda, A; + view all
(2018)
Brentuximab vedotin prior to allogeneic stem cell transplantation in Hodgkin lymphoma: a report from the EBMT Lymphoma Working Party.
British Journal of Haematology
, 181
(1)
pp. 86-96.
10.1111/bjh.15152.
|
|
Beck, M;
Hughes, D;
Kampmann, C;
Pintos-Morell, G;
Ramaswami, U;
West, ML;
Giugliani, R;
(2018)
Long-term outcomes with agalsidase alfa enzyme replacement therapy: Analysis using deconstructed composite events.
Molecular Genetics and Metabolism Reports
, 14
pp. 31-35.
10.1016/j.ymgmr.2017.10.008.
|
|
|
Biegstraaten, M;
Cox, TM;
Belmatoug, N;
Berger, MG;
Collin-Histed, T;
Vom Dahl, S;
Di Rocco, M;
... Hollak, CE; + view all
(2018)
Management goals for type 1 Gaucher disease: An expert consensus document from the European working group on Gaucher disease.
Blood Cells, Molecules, and Diseases
, 68
pp. 203-208.
10.1016/j.bcmd.2016.10.008.
|
|
Burnett, AK;
Das Gupta, E;
Knapper, S;
Khwaja, A;
Sweeney, M;
Kjeldsen, L;
Hawkins, T;
... Russell, NH; + view all
(2018)
The Addition Of The MTORr Inhibitor, Everolimus, To Consolidation Therapy In Acute Myeloid Leukaemia: Experience From The UK NCRI AML17 Trial.
Haematologica
10.3324/haematol.2018.189514.
(In press).
|
|
C
|
Cappellini, MD;
Porter, JB;
Viprakasit, V;
Taher, AT;
(2018)
A paradigm shift on beta-thalassaemia treatment: How will we manage this old disease with new therapies?
Blood Reviews
, 32
(4)
pp. 300-311.
10.1016/j.blre.2018.02.001.
|
|
|
Carty, F;
Corbett, JM;
Cunha, JPMCM;
Reading, JL;
Tree, TIM;
Ting, AE;
Stubblefield, SR;
(2018)
Multipotent Adult Progenitor Cells Suppress T Cell Activation in In Vivo Models of Homeostatic Proliferation in a Prostaglandin E2-Dependent Manner.
Frontiers In Immunology
, 9
, Article 645. 10.3389/fimmu.2018.00645.
|
|
|
Chakravarthy, A;
Furness, A;
Joshi, K;
Ghorani, E;
Ford, K;
Ward, MJ;
King, EV;
... Fenton, TR; + view all
(2018)
Author Correction: Pan-cancer deconvolution of tumour composition using DNA methylation.
[Corrigendum].
Nature Communications
, 9
, Article 4642. 10.1038/s41467-018-07155-4.
|
|
|
Chakravarthy, A;
Furness, A;
Joshi, K;
Ghorani, E;
Ford, K;
Ward, MJ;
King, EV;
... Fenton, TR; + view all
(2018)
Pan-cancer deconvolution of tumour composition using DNA methylation.
Nature Communications
, 9
, Article 3220. 10.1038/s41467-018-05570-1.
|
 |
|
Chapman, MA;
Sive, J;
Ambrose, J;
Roddie, C;
Counsell, N;
Lach, A;
Abbasian, M;
... Yong, K; + view all
(2018)
RNA-Seq of newly diagnosed patients in the PADIMAC study leads to a bortezomib/lenalidomide decision signature.
Blood
, 132
(20)
pp. 2154-2165.
10.1182/blood-2018-05-849893.
|
|
Cohen, H;
Efthymiou, M;
Gates, C;
Isenberg, D;
(2018)
Direct Oral Anticoagulants for Thromboprophylaxis in Patients with Antiphospholipid Syndrome.
Seminars in Thrombosis and Hemostasis
, 44
(05)
pp. 427-438.
10.1055/s-0036-1597902.
|
|
|
Cohen, H;
Efthymiou, M;
Isenberg, DA;
(2018)
Use of direct oral anticoagulants in antiphospholipid syndrome.
Journal of Thrombosis and Haemostasis
, 16
(6)
pp. 1028-1039.
10.1111/jth.14017.
|
|
Coughtrey, A;
Millington, A;
Bennett, S;
Christie, D;
Hough, R;
Su, M;
Constantinou, M;
(2018)
The Effectiveness of Psychosocial Interventions for Psychological Outcomes in Paediatric Oncology: A Systematic Review.
Journal of Pain and Symptom Management
, 55
(3)
pp. 1004-1017.
10.1016/j.jpainsymman.2017.09.022.
|
D
|
Day, E;
Jones, L;
Langner, R;
Stirling, LC;
Hough, R;
Bluebond-Langner, M;
(2018)
"We just follow the patients' lead": Healthcare professional perspectives on the involvement of teenagers with cancer in decision-making.
Pediatric Blood and Cancer
, 65
(3)
, Article e26898. 10.1002/pbc.26898.
|
|
|
Diot, A;
Agnew, T;
Sanderson, J;
Liao, C;
Carver, J;
Neves, RPD;
Gupta, R;
... Poulton, J; + view all
(2018)
Validating the RedMIT/GFP-LC3 Mouse Model by Studying Mitophagy in Autosomal Dominant Optic Atrophy Due to the OPA1Q285STOP Mutation.
Frontiers in Cell and Developmental Biology
, 6
, Article 103. 10.3389/fcell.2018.00103.
|
|
E
|
Efthymiou, M;
Arachchillage, DRJ;
Lane, PJ;
O'Keeffe, AG;
McDonnell, T;
Cohen, H;
Mackie, IJ;
(2018)
Antibodies against TFPI and protein C are associated with a severe thrombotic phenotype in patients with and without antiphospholipid syndrome.
Thrombosis Research
, 170
pp. 60-68.
10.1016/j.thromres.2018.08.003.
|
|
El-Sharkawi, D;
Sproul, D;
Allen, CG;
Feber, A;
Wright, M;
Hills, RK;
Linch, DC;
(2018)
Variable Outcome And Methylation Status According To CEBPA Mutant Type In Double-Mutated Acute Myeloid Leukemia Patients And The Possible Implications For Treatment.
Haematologica
, 103
(1)
pp. 91-100.
10.3324/haematol.2017.173096.
|
|
F
|
Farah, N;
Kirkwood, AA;
Rahman, S;
Leon, T;
Jenkinson, S;
Gale, RE;
Patrick, K;
... Mansour, MR; + view all
(2018)
Prognostic impact of the absence of biallelic deletion at theTRGlocus for pediatric patients with T-cell acute lymphoblastic leukemia treated on the MRC UKALL2003 trial.
Haematologica
, 103
(7)
e288-e292.
10.3324/haematol.2017.185801.
|
|
|
Fehniger, TA;
Miller, JS;
Stuart, RK;
Cooley, S;
Salhotra, A;
Curtsinger, J;
Westervelt, P;
... Rowinsky, E; + view all
(2018)
A Phase 1 Trial of CNDO-109-Activated Natural Killer Cells in Patients with High-Risk Acute Myeloid Leukemia.
Biology of Blood and Marrow Transplantation
, 24
(8)
pp. 1581-1589.
10.1016/j.bbmt.2018.03.019.
|
|
|
Fortmann, J;
Fisher, A;
Hough, R;
Gregory, A;
Pugh, G;
(2018)
Sleep Quality, Fatigue and Quality of Life among Teenage and Young Adult Cancer Survivors.
Journal of Adolescent and Young Adult Oncology
10.1089/jayao.2018.0004.
|
|
Fox, T;
Chakraverty, R;
Burns, S;
Carpenter, B;
Thomson, K;
Lowe, D;
Fielding, A;
... Morris, EC; + view all
(2018)
Successful outcome following allogeneic hematopoietic stem cell transplantation in adults with primary immunodeficiency.
Blood
, 131
(8)
pp. 917-931.
10.1182/blood-2017-09-807487.
|
|
Fox, TA;
Jager, R;
Ardeshna, KM;
(2018)
Cerebrospinal fluid leak after bone marrow biopsy.
British Journal of Haematology
, 180
(3)
p. 319.
10.1111/bjh.14963.
|
|
Freeman, SD;
Hills, RK;
Virgo, P;
Khan, N;
Couzens, S;
Dillon, R;
Gilkes, A;
... Russell, NH; + view all
(2018)
Measurable Residual Disease at Induction Redefines Partial Response in Acute Myeloid Leukemia and Stratifies Outcomes in Patients at Standard Risk Without NPM1 Mutations.
Journal of Clinical Oncology
, 36
(15)
pp. 1486-1497.
10.1200/JCO.2017.76.3425.
|
|
Furness, CL;
Mansur, MB;
Weston, VJ;
Ermini, L;
van Delft, FW;
Jenkinson, S;
Gale, R;
... Greaves, M; + view all
(2018)
The subclonal complexity of STIL-TAL1+ T-cell acute lymphoblastic leukaemia.
Leukemia
, 32
pp. 1984-1993.
10.1038/s41375-018-0046-8.
|
G
|
Gale, RE;
Popa, T;
Wright, M;
Khan, N;
Freeman, SD;
Burnett, AK;
Russell, NH;
... Linch, DC; + view all
(2018)
No evidence that CD33 splicing SNP impacts the response to GO in younger adults with AML treated on UK MRC/NCRI trials.
Blood
, 131
(4)
pp. 468-471.
10.1182/blood-2017-08-802157.
|
|
García-Berrocoso, T;
Llombart, V;
Colàs-Campàs, L;
Hainard, A;
Licker, V;
Penalba, A;
Ramiro, L;
... Montaner, J; + view all
(2018)
Single Cell Immuno-Laser Microdissection Coupled to Label-Free Proteomics to Reveal the Proteotypes of Human Brain Cells After Ischemia.
Molecular & Cellular Proteomics
, 17
(1)
pp. 175-189.
10.1074/mcp.RA117.000419.
|
|
Gassas, A;
Sivaprakasam, P;
Cummins, M;
Breslin, P;
Patrick, K;
Slatter, M;
Skinner, R;
... Amrolia, P; + view all
(2018)
High transplant-related mortality associated with haematopoietic stem cell transplantation for paediatric therapy-related acute myeloid leukaemia (t-AML). A study on behalf of the United Kingdom Paediatric Blood and Bone Marrow Transplant Group.
Bone Marrow Transplantation
, 53
(9)
pp. 1165-1169.
10.1038/s41409-018-0157-x.
|
|
|
Ghorani, E;
Quezada, SA;
(2018)
Chromatin regulation and immune escape.
Science
, 359
(6377)
pp. 745-746.
10.1126/science.aat0383.
|
|
Ghorani, E;
Rosenthal, R;
McGranahan, N;
Reading, JL;
Lynch, M;
Peggs, KS;
Swanton, C;
(2018)
Differential binding affinity of mutated peptides for MHC class I is a predictor of survival in advanced lung cancer and melanoma.
Annals of Oncology
, 29
(1)
pp. 271-279.
10.1093/annonc/mdx687.
|
|
|
Glynne-Jones, R;
Hall, MR;
Lopes, A;
Pearce, S;
Goh, V;
Bosompem, S;
Bridgewater, J;
... Harrison, M; + view all
(2018)
BACCHUS: A randomised non-comparative phase II study of neoadjuvant chemotherapy (NACT) in patients with locally advanced rectal cancer (LARC).
Heliyon
, 4
(9)
, Article e00804. 10.1016/j.heliyon.2018.e00804.
|
|
|
Gohil, Satyen Harish;
(2018)
Pre-clinical development of novel ROR1 chimeric antigen receptor T cells and bispecific T cell engagers.
Doctoral thesis (Ph.D), UCL (University College London).
|
|
Gohil, SH;
Maciocia, N;
Patrick, P;
Roberts, T;
Counsell, N;
Smith, P;
Clifton-Hadley, L;
... Nathwani, AC; + view all
(2018)
LenD: a study to establish the safety and efficacy of lenalidomide and dexamethasone in patients with relapsed or refractory chronic lymphocytic leukemia.
Leukemia & Lymphoma
, 59
(7)
pp. 1730-1733.
10.1080/10428194.2017.1399311.
|
|
Gonzalez-McQuire, S;
Yong, K;
Leleu, H;
Mennini, FS;
Flinois, A;
Gazzola, C;
Schoen, P;
... Fink, L; + view all
(2018)
Healthcare resource utilization among patients with relapsed multiple myeloma in the UK, France, and Italy.
Journal of Medical Economics
, 21
(5)
pp. 450-467.
10.1080/13696998.2017.1421546.
|
|
Gootjes, EC;
Bakkerus, L;
ten Tije, AJ;
Witteveen, PO;
Buffart, TE;
Bridgewater, JA;
Primrose, JN;
... Verheul, HMW; + view all
(2018)
The value of tumour debulking for patients with extensive multi-organ metastatic colorectal cancer.
European Journal of Cancer Prevention
, 103
pp. 160-164.
10.1016/j.ejca.2018.07.012.
|
H
|
Hendriksz, CJ;
Parini, R;
AlSayed, MD;
Raiman, J;
Giugliani, R;
Mitchell, JJ;
Burton, BK;
... Harmatz, PR; + view all
(2018)
Impact of long-term elosulfase alfa on activities of daily living in patients with Morquio A syndrome in an open-label, multi-center, phase 3 extension study.
Molecular Genetics and Metabolism
, 123
(2)
pp. 127-134.
10.1016/j.ymgme.2017.11.015.
|
|
|
Hill, AG;
Findlay, M;
Burge, M;
Jackson, C;
García Alfonso, P;
Samuel, L;
Ganju, V;
... Tabernero, J; + view all
(2018)
Phase II study of the dual EGFR/HER3 inhibitor duligotuzumab (MEHD7945A) vs. cetuximab in combination with FOLFIRI in RAS wild-type metastatic colorectal cancer.
Clinical Cancer Research
, 42
(10)
pp. 2276-2284.
10.1158/1078-0432.CCR-17-0646.
|
|
Hotblack, A;
Holler, A;
Piapi, A;
Ward, S;
Strauss, HJ;
Bennett, CL;
(2018)
Tumor-resident dendritic cells and macrophages modulate the accumulation of TCR-engineered T cells in melanoma.
Molecular Therapy
, 26
(6)
pp. 1471-1481.
10.1016/j.ymthe.2018.03.011.
|
|
|
Hynds, RE;
Ben Aissa, A;
Gowers, KHC;
Watkins, TBK;
Bosshard-Carter, L;
Rowan, AJ;
Veeriah, S;
... Janes, SM; + view all
(2018)
Expansion of airway basal epithelial cells from primary human non-small cell lung cancer tumors.
International Journal of Cancer
, 143
(1)
pp. 160-166.
10.1002/ijc.31383.
|
|
I
|
Iveson, TJ;
Kerr, RS;
Saunders, MP;
Cassidy, J;
Henrik Hollander, N;
Tabernero, J;
Haydon, A;
... Paul, J; + view all
(2018)
3 versus 6 months of adjuvant oxaliplatin-fluoropyrimidine combination therapy for colorectal cancer (SCOT): an international, randomised, phase 3, non-inferiority trial.
Lancet Oncology
, 19
(4)
pp. 562-578.
10.1016/S1470-2045(18)30093-7.
|
|
J
|
Jaffer, S;
Goh, P;
Abbasian, M;
Nathwani, AC;
(2018)
Mbd3 Promotes Reprogramming of Primary Human Fibroblasts.
International Journal of Stem Cells
, 11
(2)
pp. 235-241.
10.15283/ijsc18036.
|
|
K
|
Khan, AB;
Carpenter, B;
Sousa, PSE;
Pospori, C;
Khorshed, R;
Griffin, J;
Veliça, P;
... Chakraverty, R; + view all
(2018)
Redirection to the bone marrow improves T cell persistence and antitumor functions.
The Journal of Clinical Investigation
, 128
(5)
pp. 2010-2024.
10.1172/JCI97454.
|
|
L
|
Lavalle, L;
Thomas, AS;
Beaton, B;
Ebrahim, H;
Reed, M;
Ramaswami, U;
Elliott, P;
... Hughes, DA; + view all
(2018)
Phenotype and biochemical heterogeneity in late onset Fabry disease defined by N215S mutation.
PLoS One
, 13
(4)
, Article e0193550. 10.1371/journal.pone.0193550.
|
|
|
Lee, DW;
Santomasso, BD;
Locke, FL;
Ghobadi, A;
Turtle, CJ;
Brudno, JN;
Maus, MV;
... Neelapu, SS; + view all
(2018)
ASBMT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells.
Biology of Blood and Marrow Transplantation
10.1016/j.bbmt.2018.12.758.
(In press).
|
|
|
Ling, G;
Nathwani, AC;
Tuddenham, EGD;
(2018)
Recent advances in developing specific therapies for haemophilia.
British Journal of Haematology
, 181
(2)
pp. 161-172.
10.1111/bjh.15084.
|
M
|
M F Silva, J;
Ladomenou, F;
Carpenter, B;
Chandra, S;
Sedlacek, P;
Formankova, R;
Grandage, V;
... Veys, P; + view all
(2018)
Allogeneic hematopoietic stem cell transplantation for severe, refractory juvenile idiopathic arthritis.
Blood Adv
, 2
(7)
pp. 777-786.
10.1182/bloodadvances.2017014449.
|
|
Mac Lochlainn, DJ;
McKechnie, DGJ;
Mehta, AB;
Hughes, DA;
(2018)
The utility of the FIPI score in predicting long-term clinical outcomes in patients with Fabry disease receiving enzyme replacement therapy with agalsidase alfa.
Molecular Genetics and Metabolism
, 123
(2)
pp. 154-158.
10.1016/j.ymgme.2017.10.001.
|
|
Mansour, MR;
He, S;
Li, Z;
Lobbardi, R;
Abraham, BJ;
Hug, C;
Rahman, S;
... Look, TA; + view all
(2018)
JDP2: An oncogenic bZIP transcription factor in T cell acute lymphoblastic leukemia.
Journal of Experimental Medicine
, 215
(7)
, Article 1929. 10.1084/jem.20170484.
|
|
Manwani, R;
Hegenbart, U;
Mahmood, S;
Sachchithanantham, S;
Kyriakou, C;
Yong, K;
Popat, R;
... Wechalekar, A; + view all
(2018)
Deferred autologous stem cell transplantation in systemic AL amyloidosis.
Blood Cancer Journal
, 8
, Article 101. 10.1038/s41408-018-0137-9.
|
|
|
Marzolini, MAV;
Akarca, A;
Teng, K;
Marafioti, T;
Gohil, S;
Nathwani, A;
Newell, E;
... Peggs, K; + view all
(2018)
Cytotoxic CD4+ Cells in Chronic Lymphocytic Leukaemia: An Extended Immunophenotypic Analysis Examining Their Association with Cytomegalovirus Serostatus and Similarities with Cytotoxic CD8+ Cells.
Blood
, 132
(suppl 1)
p. 3130.
10.1182/blood-2018-99-116798.
|
|
Mathew, NR;
Baumgartner, F;
Braun, L;
O'Sullivan, D;
Thomas, S;
Waterhouse, M;
Mueller, TA;
... Zeiser, R; + view all
(2018)
Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells.
Nature Medicine
, 24
(3)
pp. 282-291.
10.1038/nm.4484.
|
|
Mehrban, N;
Bowen, J;
Tait, A;
Darbyshire, A;
Virasami, AK;
Lowdell, MW;
Birchall, MA;
(2018)
Silsesquioxane polymer as a potential scaffold for laryngeal reconstruction.
Materials Science and Engineering C
, 92
pp. 565-574.
10.1016/j.msec.2018.07.003.
|
|
|
Mekkaoui, L;
Parekh, F;
Kotsopoulou, E;
Darling, D;
Dickson, G;
Cheung, G;
Chan, L;
... Pule, M; + view all
(2018)
Lentiviral Vector Purification Using Genetically Encoded Biotin Mimic in Packaging Cell.
Molecular Therapy: Methods and Clinical Development
, 11
pp. 155-165.
10.1016/j.omtm.2018.10.008.
|
|
|
Mekkaoui, Leila;
(2018)
Lentiviral vector purification using genetically encoded biotin mimic in packaging cell.
Doctoral thesis (Ph.D), UCL (University College London).
|
|
Miller, PDE;
Forster, AS;
de Silva, TI;
Leonard, H;
Anthias, C;
Mayhew, M;
Klammer, M;
... A Snowden, J; + view all
(2018)
Sociodemographic and psychological determinants of influenza vaccine intention among recipients of autologous and allogeneic haematopoietic stem cell transplant: a cross-sectional survey of UK transplant recipients using a modified health belief model.
BMJ Open
, 8
(8)
, Article e021222. 10.1136/bmjopen-2017-021222.
|
|
|
Monypenny, J;
Milewicz, H;
Flores-Borja, F;
Weitsman, G;
Cheung, A;
Chowdhury, R;
Burgoyne, T;
... Ng, T; + view all
(2018)
ALIX Regulates Tumor-Mediated Immunosuppression by Controlling EGFR Activity and PD-L1 Presentation.
Cell Reports
, 24
(3)
pp. 630-641.
10.1016/j.celrep.2018.06.066.
|
|
|
Mullin, S;
Hughes, D;
Mehta, A;
Schapira, AHV;
(2018)
Neurological effects of glucocerebrosidase gene mutations.
European Journal of Neurology
10.1111/ene.13837.
(In press).
|
|
Munis, AM;
Tijani, M;
Hassall, M;
Mattiuzzo, G;
Collins, MK;
Takeuchi, Y;
(2018)
Characterisation of Antibody Interactions with the G Protein of Vesicular Stomatitis Virus Indiana Strain and Other Vesiculovirus G Proteins.
Journal of Virology
10.1128/JVI.00900-18.
|
|
N
|
Nordin, S;
Kozor, R;
Baig, S;
Abdel-Gadir, A;
Medina-Menacho, K;
Rosmini, S;
Captur, G;
... Moon, JC; + view all
(2018)
Cardiac Phenotype of Prehypertrophic Fabry Disease.
Circulation: Cardiovascular Imaging
, 11
(6)
, Article e007168. 10.1161/CIRCIMAGING.117.007168.
|
|
|
Nordin, S;
Kozor, R;
Medina-Menacho, K;
Abdel-Gadir, A;
Baig, S;
Sado, DM;
Lobascio, I;
... Moon, JC; + view all
(2018)
Proposed Stages of Myocardial Phenotype Development in Fabry Disease.
JACC Cardiovasc Imaging
10.1016/j.jcmg.2018.03.020.
(In press).
|
O
|
O'Connor, D;
Enshaei, A;
Bartram, J;
Hancock, J;
Harrison, CJ;
Hough, R;
Samarasinghe, S;
... Goulden, N; + view all
(2018)
Genotype-Specific Minimal Residual Disease Interpretation Improves Stratification in Pediatric Acute Lymphoblastic Leukemia.
Journal of Clinical Oncology
, 36
(1)
pp. 34-43.
10.1200/JCO.2017.74.0449.
|
|
P
|
Paul-Smith, MC;
Pytel, KM;
Gelinas, J-F;
McIntosh, J;
Pringle, I;
Davies, L;
Chan, M;
... Griesenbach, U; + view all
(2018)
The murine lung as a factory to produce secreted intrapulmonary and circulatory proteins.
Gene Therapy
, 35
pp. 345-358.
10.1038/s41434-018-0025-8.
|
|
|
Paulk, NK;
Pekrun, K;
Zhu, E;
Nygaard, S;
Li, B;
Xu, J;
Chu, K;
... Kay, MA; + view all
(2018)
Bioengineered AAV Capsids with Combined High Human Liver Transduction In Vivo and Unique Humoral Seroreactivity.
Molecular Therapy
, 26
(1)
pp. 289-303.
10.1016/j.ymthe.2017.09.021.
|
|
|
Pereira, SP;
Jitlal, M;
Duggan, M;
Lawrie, E;
Beare, S;
O'Donoghue, P;
Wasan, HS;
... PHOTOSTENT-02 investigators, .; + view all
(2018)
PHOTOSTENT-02: porfimer sodium photodynamic therapy plus stenting versus stenting alone in patients with locally advanced or metastatic biliary tract cancer.
ESMO Open
, 3
(5)
, Article e000379. 10.1136/esmoopen-2018-000379.
|
|
|
Phyu, P;
Merwick, A;
Davagnanam, I;
Bolsover, F;
Jichi, F;
Wheeler-Kingshott, C;
Golay, X;
... Werring, DJ; + view all
(2018)
Increased resting cerebral blood flow in adult Fabry disease: MRI arterial spin labeling study.
Neurology
, 90
(16)
e1379-e1385.
10.1212/WNL.0000000000005330.
|
|
Piddock, RE;
Marlein, CR;
Abdul-Aziz, A;
Shafat, MS;
Auger, MJ;
Bowles, KM;
Rushworth, SA;
(2018)
Myeloma-derived macrophage inhibitory factor regulates bone marrow stromal cell-derived IL-6 via c-MYC.
[Letter].
Journal of Hematology & Oncology
, 11
(1)
, Article 66. 10.1186/s13045-018-0614-4.
|
|
|
Pihan, M;
Keddie, S;
D'Sa, S;
Church, AJ;
Yong, KL;
Reilly, MM;
Lunn, MP;
(2018)
Raised VEGF: High sensitivity and specificity in the diagnosis of POEMS syndrome.
Neurology, Neuroimmunology & Neuroinflammation
, 5
(5)
, Article e486. 10.1212/NXI.0000000000000486.
|
|
|
Porter, JB;
Garbowski, MW;
(2018)
Interaction of Transfusion and Iron Chelation in Thalassemias.
Hematology/Oncology Clinics of North America
, 32
(2)
pp. 247-259.
10.1016/j.hoc.2017.11.010.
|
|
Pugh, G;
Hough, R;
Gravestock, H;
Haddrell, JB;
Beeken, RJ;
Fisher, A;
(2018)
The Lifestyle Information and Intervention Preferences of Teenage and Young Adult Cancer Survivors: A Qualitative Study.
Cancer Nursing
, 41
(5)
pp. 389-398.
10.1097/NCC.0000000000000508.
|
Q
|
Quezada, SA;
Peggs, KS;
(2018)
Lost in Translation: Deciphering the mechanism of action of anti-human CTLA-4.
Clinical Cancer Research
10.1158/1078-0432.CCR-18-2509.
(In press).
|
R
|
Ramirez, G;
Cohen, H;
Mackie, I;
Isenberg, D;
Efthymiou, M;
(2018)
Prevalence of anti-protein C antibodies and acquired activated protein C resistance and in systemic lupus erythematosus.
Presented at: British Society for Haemostasis and Thrombosis, Coventry, UK.
|
|
|
Reading, JL;
Gálvez-Cancino, F;
Swanton, RC;
Lladser, A;
Peggs, K;
Quezada, S;
(2018)
The function and dysfunction of memory CD8+ T cells in tumor immunity.
Immunological Reviews
, 283
(1)
pp. 194-212.
10.1111/imr.12657.
|
|
Reekie, I;
Irish, D;
Ijaz, S;
Fox, T;
Bharucha, T;
Griffiths, P;
Thorburn, D;
... Sekhar, M; + view all
(2018)
Hepatitis E Infection in Stem Cell and Solid Organ Transplantpatients: a Cross-sectional Study the Importance of Hev Rna Screening in Peri-transplant Period.
Journal of Clinical Virology
, 107
pp. 1-5.
10.1016/j.jcv.2018.07.011.
|
|
Robinson, J;
Guethlein, LA;
Maccari, G;
Blokhuis, J;
Bimber, BN;
de Groot, NG;
Sanderson, ND;
... Parham, P; + view all
(2018)
Nomenclature for the KIR of non-human species.
Immunogenetics
, 70
(9)
pp. 571-583.
10.1007/s00251-018-1064-4.
|
|
|
Robles-Zurita, J;
Boyd, KA;
Briggs, AH;
Iveson, T;
Kerr, RS;
Saunders, MP;
Cassidy, J;
... Paul, J; + view all
(2018)
SCOT: a comparison of cost-effectiveness from a large randomised phase III trial of two durations of adjuvant Oxaliplatin combination chemotherapy for colorectal cancer.
British Journal of Cancer
, 119
pp. 1332-1338.
10.1038/s41416-018-0319-z.
|
|
|
Ryland, GL;
Jones, K;
Chin, M;
Markham, J;
Aydogan, E;
Kankanige, Y;
Caruso, M;
... Blombery, P; + view all
(2018)
Novel genomic findings in multiple myeloma identified through routine diagnostic sequencing.
Journal of Clinical Pathology
, 71
(10)
pp. 895-899.
10.1136/jclinpath-2018-205195.
|
|
S
|
Sage, E;
Davies, A;
Kolluri, K;
Patrick, S;
Weil, B;
Rego, RVTP;
Edwards, A;
... Janes, SM; + view all
(2018)
Targeted stem cells expressing TRAIL as a therapy for lung Cancer TACTICAL: a phase I/II trial.
Lung Cancer
, 115
(Supp. 1)
S87-S87.
10.1016/S0169-5002(18)30222-8.
|
|
Samson, A;
Scott, KJ;
Taggart, D;
West, EJ;
Wilson, E;
Nuovo, GJ;
Thomson, S;
... Melcher, AA; + view all
(2018)
Intravenous delivery of oncolytic reovirus to brain tumor patients immunologically primes for subsequent checkpoint blockade.
Science Translational Medicine
, 10
(422)
, Article eaam7577. 10.1126/scitranslmed.aam7577.
|
|
|
Sanchez-Paulete, AR;
Teijeira, A;
Quetglas, JI;
Rodriguez-Ruiz, ME;
Sanchez-Arraez, A;
Labiano, S;
Etxeberria, I;
... Melero, I; + view all
(2018)
Intratumoral immunotherapy with XCL1 and sFlt3L encoded in recombinant Semliki Forest Virus-derived vectors fosters dendritic cell-mediated T cell cross-priming.
Cancer Research
10.1158/0008-5472.CAN-18-0933.
|
|
Santos e Sousa, P;
Bennett, CL;
Chakraverty, R;
(2018)
Unraveling the Mechanisms of Cutaneous Graft-Versus-Host Disease.
Frontiers In Immunology
, 9
, Article 963. 10.3389/fimmu.2018.00963.
|
|
|
Santos e Sousa, P;
Ciré, S;
Conlan, T;
Jardine, L;
Tkacz, C;
Ferrer, IR;
Lomas, C;
... Chakraverty, R; + view all
(2018)
Peripheral tissues re-program CD8+ T cells for pathogenicity during graftversus- host disease.
JCI Insight
, 3
(5)
, Article e97011. 10.1172/jci.insight.97011.
|
|
|
Schiff, ER;
Frampton, M;
Ben-Yosef, N;
Avila, BE;
Semplici, F;
Pontikos, N;
Bloom, SL;
... Levine, AP; + view all
(2018)
Rare coding variant analysis in a large cohort of Ashkenazi Jewish families with inflammatory bowel disease.
Human Genetics
, 137
(9)
pp. 723-734.
10.1007/s00439-018-1927-7.
|
 |
|
Schiff, ER;
Frampton, M;
Semplici, F;
Bloom, SL;
McCartney, SA;
Vega, R;
Lovat, LB;
... Levine, AP; + view all
(2018)
A New Look at Familial Risk of Inflammatory Bowel Disease in the Ashkenazi Jewish Population.
Digestive Diseases and Sciences
, 63
(11)
pp. 3049-3057.
10.1007/s10620-018-5219-9.
|
|
Schiffmann, R;
Bichet, DG;
Jovanovic, A;
Hughes, DA;
Giugliani, R;
Feldt-Rasmussen, U;
Shankar, SP;
... Nicholls, K; + view all
(2018)
Migalastat improves diarrhea in patients with Fabry disease: clinical-biomarker correlations from the phase 3 FACETS trial.
Orphanet Journal of Rare Diseases
, 13
(1)
, Article 68. 10.1186/s13023-018-0813-7.
|
|
|
Sekhar, M;
Pocock, R;
Lowe, D;
Mitchell, C;
Marafioti, T;
Dickinson, R;
Collin, M;
(2018)
Can somatic GATA2 mutation mimic germ line GATA2 mutation?
Blood Advances
, 2
(8)
pp. 904-908.
10.1182/bloodadvances.2017012617.
|
|
Sellar, R;
Gale, R;
Khwaja, A;
Garbowski, M;
Loddo, M;
Stoeber, K;
Williams, GH;
(2018)
Immunophenotypic analysis of cell cycle status in acute myeloid leukaemia: relationship to cytogenetics, genotype and clinical outcome.
British Journal of Haematology
, 181
(4)
pp. 486-494.
10.1111/bjh.15211.
|
|
Sellar, RS;
Rowntree, C;
Vora, AJ;
Furness, CL;
Goulden, N;
Mitchell, C;
Moorman, AV;
(2018)
Relapse in teenage and young adult patients treated on a paediatric minimal residual disease stratified ALL treatment protocol is associated with a poor outcome: results from UKALL2003.
British Journal of Haematology
, 181
(4)
pp. 515-522.
10.1111/bjh.15208.
|
|
Sharma, R;
Hughes, D;
Ramaswami, U;
Cole, D;
Roberts, M;
Hendriksz, CJ;
Stepien, KM;
... Jahnke, N; + view all
(2018)
Enzyme replacement therapy for late-onset Pompe disease.
Cochrane Database of Systematic Reviews
, 2018
(4)
, Article CD012993. 10.1002/14651858.CD012993.
|
|
Stavrou, M;
Philip, B;
Traynor-White, C;
Davis, CG;
Onuoha, S;
Cordoba, S;
Thomas, S;
(2018)
A Rapamycin-Activated Caspase 9-Based Suicide Gene.
Molecular Therapy
, 26
(5)
pp. 1266-1276.
10.1016/j.ymthe.2018.03.001.
|
|
|
Sunderland, MW;
Peggs, KS;
(2018)
Successful translation and future prospects of TALEN editing for leukemia patients.
Expert Opinion on Biological Therapy
, 18
(7)
pp. 725-726.
10.1080/14712598.2018.1484105.
|
|
T
|
Taher, AT;
Origa, R;
Perrotta, S;
Kouraklis, A;
Ruffo, GB;
Kattamis, A;
Goh, A-S;
... Porter, JB; + view all
(2018)
Patient-reported outcomes from a randomized phase II study of the deferasirox film-coated tablet in patients with transfusion-dependent anemias.
Health and Quality of Life Outcomes
, 16
, Article 216. 10.1186/s12955-018-1041-5.
|
|
|
Tijani, M;
Munis, AM;
Perry, C;
Sanber, K;
Ferraresso, M;
Mukhopadhyay, T;
Themis, M;
... Takeuchi, Y; + view all
(2018)
Lentivector Producer Cell Lines with Stably Expressed Vesiculovirus Envelopes.
Molecular Therapy - Methods & Clinical Development
, 10
pp. 303-312.
10.1016/j.omtm.2018.07.013.
|
|
|
Trudel, S;
Lendvai, N;
Popat, R;
Voorhees, PM;
Reeves, B;
Libby, EN;
Richardson, PG;
... Cohen, AD; + view all
(2018)
Targeting B-cell maturation antigen with GSK2857916 antibody-drug conjugate in relapsed or refractory multiple myeloma (BMA117159): a dose escalation and expansion phase 1 trial.
The Lancet Oncology
, 19
(12)
pp. 1641-1653.
10.1016/S1470-2045(18)30576-X.
|
U
|
Urbani, L;
Camilli, C;
Phylactopoulos, DE;
Crowley, C;
Natarajan, D;
Scottoni, F;
Maghsoudlou, PL;
... De Coppi, P; + view all
(2018)
Multi-stage bioengineering of a layered oesophagus with in vitro expanded muscle and epithelial adult progenitors.
Nature Communications
, 9
, Article 4286. 10.1038/s41467-018-06385-w.
|
|
V
|
Vargas, FA;
Furness, AJS;
Litchfield, K;
Joshi, K;
Rosenthal, R;
Ghorani, E;
Solomon, I;
... Quezada, SA; + view all
(2018)
Fc Effector Function Contributes to the Activity of Human Anti-CTLA-4 Antibodies.
Cancer Cell
, 33
(4)
pp. 649-663.
10.1016/j.ccell.2018.02.010.
|
|
|
Venkatesan, S;
Rosenthal, R;
Kanu, N;
McGranahan, N;
Bartek, J;
Quezada, SA;
Hare, J;
... Swanton, C; + view all
(2018)
APOBEC mutagenesis in drug resistance and immune escape in HIV and cancer evolution.
Annals of Oncology
, 29
(3)
pp. 563-572.
10.1093/annonc/mdy003.
|
|
|
Vesely, C;
Childs, A;
Wong, YNS;
Ogunbiyi, O;
Gander, A;
Luong, T;
Thirlwell, C;
... Meyer, T; + view all
(2018)
Systematic Evaluation of the Immune Microenvironment of Neuroendocrine Tumors (NET).
Presented at: 15th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Barcelona, Spain.
|
W
|
Walf-Vorderwülbecke, V;
Pearce, K;
Brooks, T;
Hubank, M;
Van den Heuvel-Eibrink, MM;
Zwaan, CM;
Adams, S;
... Williams, O; + view all
(2018)
Targeting acute myeloid leukemia by drug-induced c-MYB degradation.
Leukemia
, 32
pp. 882-889.
10.1038/leu.2017.317.
|
|
Wanner, C;
Arad, M;
Baron, R;
Burlina, A;
Elliott, PM;
Feldt-Rasmussen, U;
Fomin, VV;
... Hilz, MJ; + view all
(2018)
European expert consensus statement on therapeutic goals in Fabry disease.
Molecular Genetics and Metabolism
, 124
(3)
pp. 189-203.
10.1016/j.ymgme.2018.06.004.
|
|
|
West, HC;
Bennett, CL;
(2018)
Redefining the role of Langerhans cells as immune regulators within the skin.
Frontiers in Immunology
, 8
, Article 1941. 10.3389/fimmu.2017.01941.
|
|
|
Westerland, OA;
Pratt, G;
Kazmi, M;
El-Najjar, I;
Streetly, M;
Yong, K;
Morris, M;
... British Society of Haematology Imaging Practice Guidelines Worki; + view all
(2018)
National survey of imaging practice for suspected or confirmed plasma cell malignancies.
British Journal of Radiology
, 91
(1092)
10.1259/bjr.20180462.
(In press).
|
|
|
Wilson, D;
Ambler, G;
Banerjee, G;
Shakeshaft, C;
Cohen, H;
Yousry, TA;
Al-Shahi Salman, R;
... Werring, DJ; + view all
(2018)
Early versus late anticoagulation for ischaemic stroke associated with atrial fibrillation: multicentre cohort study.
Journal of Neurology, Neurosurgery & Psychiatry
, 90
(3)
pp. 320-325.
10.1136/jnnp-2018-318890.
|
|
Wilson, D;
Ambler, G;
Shakeshaft, C;
Brown, MM;
Charidimou, A;
Salman, RA-S;
Lip, GYH;
... Werring, DJ; + view all
(2018)
Cerebral microbleeds and intracranial haemorrhage risk in patients anticoagulated for atrial fibrillation after acute ischaemic stroke or transient ischaemic attack (CROMIS-2): a multicentre observational cohort study.
The Lancet Neurology
, 17
(6)
pp. 539-547.
10.1016/S1474-4422(18)30145-5.
|
|
|
Wong, YNS;
Joshi, K;
Khetrapal, P;
Ismail, M;
Reading, JL;
Sunderland, MW;
Georgiou, A;
... Quezada, SA; + view all
(2018)
Urine-derived lymphocytes as a non-invasive measure of the bladder tumor immune microenvironment.
Journal of Experimental Medicine
, 215
(11)
pp. 2748-2759.
10.1084/jem.20181003.
|
|
